Medicine and Dentistry
Patient
100%
Donor
98%
Transplantation
80%
Kidney Transplantation
69%
Kidney
35%
Cells
30%
Kidney Graft
29%
Graft Survival
26%
Acute Graft Rejection
23%
Biopsy
22%
Kidney Allograft
20%
Nephrectomy
19%
Kidney Function
19%
Therapeutic Procedure
19%
Age
18%
Diabetes Mellitus
17%
Glomerular Filtration Rate
16%
Serum
15%
Graft Failure
15%
Incidence
15%
Immunoglobulin A Nephropathy
14%
Mycophenolic Acid
13%
Glucose
13%
Follow up
13%
Cyclosporine
12%
Antibody
11%
Allograft
11%
Creatinine
11%
Culture
10%
Thalidomide
10%
Tacrolimus
10%
Antibody Mediated Rejection
10%
Inpatient
10%
Recurrent Disease
9%
Survival Rate
9%
Insulin
9%
Human Leukocyte Antigen
9%
Rapamycin
9%
Rituximab
8%
Chronic Kidney Disease
8%
Insulin Release
8%
Tumor Spheroid
8%
Tissues
8%
Male
8%
Combination Therapy
8%
Morphology
8%
Organ
8%
Immunosuppressive Drug
8%
Nephropathy
8%
Programmed Cell Death
7%
Immunology and Microbiology
Transplantation
56%
Kidney Transplantation
26%
Kidney
16%
Monospecific Antibody
14%
Acute Graft Rejection
14%
Allotransplantation
13%
Human Leukocyte Antigen
12%
Cells
11%
Creatinine Blood Level
10%
Mycophenolic Acid
10%
Survival
10%
Immunosuppressive Drug
10%
Hepatitis B Virus
10%
Thalidomide
8%
Species
8%
Incidence
8%
Sirolimus
7%
Antibody Mediated Rejection
7%
Renal Transplantation
7%
Time
7%
Ciclosporin
6%
Age
6%
Rituximab
6%
Tacrolimus
6%
Body Weight
6%
Dexamethasone
5%
HBsAg
5%
Survival Rate
5%
Complement Dependent Cytotoxicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mycophenolate Mofetil
39%
Tacrolimus
18%
Reactive Oxygen Metabolite
12%
Immunosuppressive Agent
11%
Fibronectin
10%
Glucose
10%
Incidence
10%
Acute Graft Rejection
10%
Platelet Derived Growth Factor
9%
Rat
9%
Diabetes Mellitus
9%
Cell Proliferation
9%
Ciclosporin
9%
Everolimus
8%
Rituximab
8%
Thalidomide
8%
Graft Failure
7%
Rho Guanine Nucleotide Dissociation Inhibitor
7%
Protein
6%
Protein P53
6%
Western Blot
5%
Dexamethasone
5%
Recurrent Disease
5%
Insulin
5%
Adverse Event
5%
Sirolimus
5%
Tuberculosis
5%